{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:13:40Z","timestamp":1788930820998,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.omto.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T13:02:46Z","timestamp":1562158966000},"page":"246-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy"],"prefix":"10.1016","volume":"14","author":[{"given":"Adrian","family":"Pelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Foloppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Petryk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragunath","family":"Singaravelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Gossart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria A.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawton J.","family":"Stubbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Storbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Postigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Scut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Laight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Way","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Erbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Le Boeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2019.06.004_bib1","doi-asserted-by":"crossref","first-page":"e24643","DOI":"10.1371\/journal.pone.0024643","article-title":"A selectable and excisable marker system for the rapid creation of recombinant poxviruses","volume":"6","author":"Rintoul","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omto.2019.06.004_bib2","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1099\/jgv.0.000266","article-title":"Redundancy complicates the definition of essential genes for vaccinia virus","volume":"96","author":"Dobson","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omto.2019.06.004_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/13543784.9.2.311","article-title":"Oncolytic viruses as novel anticancer agents: turning one scourge against another","volume":"9","author":"Smith","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.omto.2019.06.004_bib4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1462-5822.2009.01327.x","article-title":"Vaccinia-induced epidermal growth factor receptor-MEK signaling and the anti-apoptotic protein F1L synergize to suppress cell death during infection","volume":"11","author":"Postigo","year":"2009","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.omto.2019.06.004_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.omto.2019.06.004_bib6","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1093\/emboj\/17.20.5948","article-title":"Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network","volume":"17","author":"Tzahar","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.omto.2019.06.004_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/hum.1994.5.7-809","article-title":"In\u00a0vivo delivery of interleukin-4 by a recombinant vaccinia virus prevents tumor development in mice","volume":"5","author":"Elkins","year":"1994","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omto.2019.06.004_bib8","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ymthe.2018.04.001","article-title":"Oncolytic virus combination therapy: killing one bird with two stones","volume":"26","author":"Martin","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2019.06.004_bib9","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1158\/0008-5472.CAN-16-2165","article-title":"Immune checkpoint blockade, immunogenic chemotherapy or IFN-\u03b1 blockade boost the local and abscopal effects of oncolytic virotherapy","volume":"77","author":"Fend","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2019.06.004_bib10","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1038\/ncomms14754","article-title":"Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omto.2019.06.004_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/gt.2013.73","article-title":"CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging","volume":"21","author":"Parviainen","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.omto.2019.06.004_bib12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/mt.2009.318","article-title":"Enhancing the therapeutic effect against ovarian cancer through a combination of viral oncolysis and antigen-specific immunotherapy","volume":"18","author":"Zhang","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2019.06.004_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ymthe.2006.05.008","article-title":"Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF","volume":"14","author":"Kim","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2019.06.004_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10358","article-title":"Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans","volume":"477","author":"Breitbach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omto.2019.06.004_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.surg.2004.04.016","article-title":"Employing tumor hypoxia to enhance oncolytic viral therapy in breast cancer","volume":"136","author":"Pin","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.omto.2019.06.004_bib16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/sj.cdd.4401853","article-title":"Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis","volume":"13","author":"Postigo","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.omto.2019.06.004_bib17","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1074\/jbc.M109.078113","article-title":"Vaccinia virus protein F1L is a caspase-9 inhibitor","volume":"285","author":"Zhai","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2019.06.004_bib18","doi-asserted-by":"crossref","first-page":"14031","DOI":"10.1128\/JVI.79.22.14031-14043.2005","article-title":"The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation","volume":"79","author":"Wasilenko","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omto.2019.06.004_bib19","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/cdd.2008.83","article-title":"Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands","volume":"15","author":"Kvansakul","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omto.2019.06.004_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/JVI.05817-11","article-title":"The vaccinia virus-encoded Bcl-2 homologues do not act as direct Bax inhibitors","volume":"86","author":"Postigo","year":"2012","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.omto.2019.06.004_bib21","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1073\/pnas.1215995110","article-title":"Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation","volume":"110","author":"Gerlic","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2019.06.004_bib22","first-page":"113","article-title":"Oncolytic viruses for treatment of malignant brain tumours","volume":"88","author":"Rainov","year":"2003","journal-title":"Acta Neurochir. Suppl. (Wien)"},{"key":"10.1016\/j.omto.2019.06.004_bib23","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1099\/vir.0.055921-0","article-title":"Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity","volume":"94","author":"Smith","year":"2013","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omto.2019.06.004_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/jir.2009.0073","article-title":"The interferon system and vaccinia virus evasion mechanisms","volume":"29","author":"Perdiguero","year":"2009","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.omto.2019.06.004_bib25","doi-asserted-by":"crossref","first-page":"40533","DOI":"10.18632\/oncotarget.17125","article-title":"Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omto.2019.06.004_bib26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/mt.2014.243","article-title":"Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients","volume":"23","author":"Cripe","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2019.06.004_bib27","first-page":"RA49","article-title":"Cytokine expression and cancer detection","volume":"15","author":"Yoo","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.omto.2019.06.004_bib28","doi-asserted-by":"crossref","first-page":"e48524","DOI":"10.1371\/journal.pone.0048524","article-title":"Deletion of the viral anti-apoptotic gene F1L in the HIV\/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens","volume":"7","author":"Perdiguero","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omto.2019.06.004_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12931-014-0087-0","article-title":"TLR4 activation induces IL-1\u03b2 release via an IPAF dependent but caspase 1\/11\/8 independent pathway in the lung","volume":"15","author":"Eltom","year":"2014","journal-title":"Respir. Res."},{"key":"10.1016\/j.omto.2019.06.004_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2005.09.032","article-title":"Near death experiences: poxvirus regulation of apoptotic death","volume":"344","author":"Taylor","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.omto.2019.06.004_bib31","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1158\/0008-5472.CAN-05-1630","article-title":"The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2","volume":"65","author":"Guo","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2019.06.004_bib32","doi-asserted-by":"crossref","first-page":"E215","DOI":"10.3390\/v9080215","article-title":"Poxviruses utilize multiple strategies to inhibit apoptosis","volume":"9","author":"Nichols","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.omto.2019.06.004_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(87)90122-3","article-title":"Plasmid and bacteriophage vectors for excision of intact inserts","volume":"57","author":"Lathe","year":"1987","journal-title":"Gene"},{"key":"10.1016\/j.omto.2019.06.004_bib34","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/gt.2008.82","article-title":"Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus","volume":"15","author":"Foloppe","year":"2008","journal-title":"Gene Ther."}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237277051930066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237277051930066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:21:46Z","timestamp":1762496506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S237277051930066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":34,"alternative-id":["S237277051930066X"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2019.06.004","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}